NM_001322934.2:c.1288C>T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001322934.2(NFKB2):​c.1288C>T​(p.Pro430Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00219 in 1,508,150 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P430L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 8 hom. )

Consequence

NFKB2
NM_001322934.2 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 1.21

Publications

3 publications found
Variant links:
Genes affected
NFKB2 (HGNC:7795): (nuclear factor kappa B subunit 2) This gene encodes a subunit of the transcription factor complex nuclear factor-kappa-B (NFkB). The NFkB complex is expressed in numerous cell types and functions as a central activator of genes involved in inflammation and immune function. The protein encoded by this gene can function as both a transcriptional activator or repressor depending on its dimerization partner. The p100 full-length protein is co-translationally processed into a p52 active form. Chromosomal rearrangements and translocations of this locus have been observed in B cell lymphomas, some of which may result in the formation of fusion proteins. There is a pseudogene for this gene on chromosome 18. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
NFKB2 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 10
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • deficiency in anterior pituitary function - variable immunodeficiency syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009656459).
BP6
Variant 10-102399458-C-T is Benign according to our data. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775. Variant chr10-102399458-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 474775.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00121 (184/152358) while in subpopulation NFE AF = 0.00207 (141/68036). AF 95% confidence interval is 0.00179. There are 1 homozygotes in GnomAd4. There are 71 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 184 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NFKB2NM_001322934.2 linkc.1288C>T p.Pro430Ser missense_variant Exon 13 of 23 ENST00000661543.1 NP_001309863.1 Q00653-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NFKB2ENST00000661543.1 linkc.1288C>T p.Pro430Ser missense_variant Exon 13 of 23 NM_001322934.2 ENSP00000499294.1 Q00653-1

Frequencies

GnomAD3 genomes
AF:
0.00121
AC:
184
AN:
152242
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00207
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000984
AC:
108
AN:
109778
AF XY:
0.000920
show subpopulations
Gnomad AFR exome
AF:
0.000242
Gnomad AMR exome
AF:
0.000417
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00184
Gnomad NFE exome
AF:
0.00189
Gnomad OTH exome
AF:
0.000633
GnomAD4 exome
AF:
0.00230
AC:
3116
AN:
1355792
Hom.:
8
Cov.:
35
AF XY:
0.00217
AC XY:
1445
AN XY:
665190
show subpopulations
African (AFR)
AF:
0.000244
AC:
7
AN:
28674
American (AMR)
AF:
0.000465
AC:
14
AN:
30114
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22738
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33768
South Asian (SAS)
AF:
0.0000930
AC:
7
AN:
75232
European-Finnish (FIN)
AF:
0.00168
AC:
78
AN:
46388
Middle Eastern (MID)
AF:
0.000192
AC:
1
AN:
5214
European-Non Finnish (NFE)
AF:
0.00275
AC:
2907
AN:
1057818
Other (OTH)
AF:
0.00183
AC:
102
AN:
55846
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
202
404
607
809
1011
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00121
AC:
184
AN:
152358
Hom.:
1
Cov.:
32
AF XY:
0.000953
AC XY:
71
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.000601
AC:
25
AN:
41582
American (AMR)
AF:
0.000261
AC:
4
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.00122
AC:
13
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00207
AC:
141
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00231
Hom.:
0
Bravo
AF:
0.00119
ExAC
AF:
0.000346
AC:
29
Asia WGS
AF:
0.000289
AC:
1
AN:
3476

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Immunodeficiency, common variable, 10 Benign:2
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 23, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NFKB2-related disorder Benign:1
Feb 17, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NFKB2: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
6.0
DANN
Benign
0.88
DEOGEN2
Benign
0.083
.;T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.071
N
LIST_S2
Benign
0.60
T;T;.
M_CAP
Benign
0.0071
T
MetaRNN
Benign
0.0097
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
M;M;M
PhyloP100
1.2
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-0.15
N;N;N
REVEL
Benign
0.040
Sift
Benign
0.20
T;T;T
Sift4G
Benign
0.68
T;T;T
Polyphen
0.011
.;B;.
Vest4
0.10
MVP
0.28
MPC
0.62
ClinPred
0.015
T
GERP RS
3.6
Varity_R
0.019
gMVP
0.27
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202001697; hg19: chr10-104159215; API